These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8238529)
21. Analysis of data from "cold saturation" radioligand binding experiments. Jeffries WB; Waugh D; Abel PW Methods Mol Biol; 1997; 73():331-42. PubMed ID: 9031220 [No Abstract] [Full Text] [Related]
22. Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions? Wittmann HJ; Strasser A Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):595-612. PubMed ID: 28220211 [TBL] [Abstract][Full Text] [Related]
23. A partially automated radioligand binding assay system for use in clinical and pharmaceutical research. Liebl B; Anhäupl T; Haen E; Günster B; Georgieff M J Recept Res; 1993; 13(1-4):369-78. PubMed ID: 8383759 [TBL] [Abstract][Full Text] [Related]
24. Improved receptor analysis in PET using a priori information from in vitro binding assays. Litton JE; Hall H; Blomqvist G Phys Med Biol; 1997 Aug; 42(8):1653-60. PubMed ID: 9279912 [TBL] [Abstract][Full Text] [Related]
25. Flow cytometry: a novel approach for the quantitative analysis of receptor--ligand interactions on surfaces of living cells. Bohn B Mol Cell Endocrinol; 1980 Oct; 20(1):1-15. PubMed ID: 6254819 [No Abstract] [Full Text] [Related]
26. Radioligand binding assays and their analysis. Maguire JJ; Kuc RE; Davenport AP Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160 [TBL] [Abstract][Full Text] [Related]
27. Microplate gel-filtration method for radioligand-binding assays. Liu J; Zacco A; Piser TM; Scott CW Anal Biochem; 2002 Sep; 308(1):127-33. PubMed ID: 12234473 [TBL] [Abstract][Full Text] [Related]
28. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay. Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789 [TBL] [Abstract][Full Text] [Related]
29. Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological context. Vauquelin G; Van Liefde I; Swinney DC Drug Discov Today Technol; 2015 Oct; 17():28-34. PubMed ID: 26724334 [TBL] [Abstract][Full Text] [Related]
30. Dual-point competition association assay: a fast and high-throughput kinetic screening method for assessing ligand-receptor binding kinetics. Guo D; van Dorp EJ; Mulder-Krieger T; van Veldhoven JP; Brussee J; Ijzerman AP; Heitman LH J Biomol Screen; 2013 Mar; 18(3):309-20. PubMed ID: 23093571 [TBL] [Abstract][Full Text] [Related]
31. Development of high-throughput radioligand binding assays for interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor (TNF-alpha) in isolated membrane preparations. Maloff BL; Delmendo RE Agents Actions; 1991 Sep; 34(1-2):132-4. PubMed ID: 1793017 [TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of parathyroid hormone receptors in rat renal cortical plasma membranes using radioligand binding. Nickols GA; Metz-Nickols MA; Pang PK; Roberts MS; Cooper CW J Bone Miner Res; 1989 Aug; 4(4):615-23. PubMed ID: 2554687 [TBL] [Abstract][Full Text] [Related]